Michael A. Caligiuri, MD

Michael A. Caligiuri, MD

President of City of Hope National Medical Center, Deana and Steve Campbell Physician-in-Chief Distinguished Chair 

Michael A. Caligiuri, MD is President of the City of Hope National Medical Center in Los Angeles California. He also holds the Deana and Steve Campbell Physician – in – Chief Distinguished Chair 

Prior to his appointment at City of Hope in February of 2018, Dr. Caligiuri was The CEO of The Ohio State University (OSU) James Cancer Hospital (2008 – 2017) and Director of OSU’s Comprehensive Cancer Center (2005 – 2017) ; he had been the Director of OSU’s Division of Hematology – Onco logy from 2000 through 2008 .

Caligiuri is a physician – scientist whose clinical work is focused in leukemia and lymphoma. His laboratory has evolved to investigate:

• Development and normal role of the body’s large granular lymphocytes called natural ki ller cells so as to exploit their properties in an effort to develop effective therapies against cancer;

• The molecular basis for the development of acute leukemia. His lab studies the pathogenesis of acute leukemia, the prognostic significance of molecu lar defects in acute leukemia, and novel immune and targeted therapies for acute leukemia.

Since 1990, more than 100 students have trained in the Caligiuri laboratory and have received over 200 awards for their research. Dr. Caligiuri has designed and conducted many clinical studies for over 1500 leu kemia and lymphoma patients. He has over 320 original publications on immunology or leukemia.

Dr. Caligiuri is an elected member of the American Association for Clinical Investigation and the American Association of Physicians, and he is an elected Fellow in the American Association for the Advancem ent of Science (AAAS) . From 2009 – 11, he served as president of the Association for American Cancer Institutes (AACI); From 2014 – 2017 he served as the president of the Society of Natural Immunity, and in 2017 he was elected president of the American Associa tion for Cancer Research (AACR), the world’s largest cancer research organization. Dr. Caligiuri has served on the National Cancer Institute (NCI) Board of Scientific Advisors and chaired the Institute of Medicine’s National Cancer Policy Forum from 2014 – 2 016 . He either chairs or is a member of 10 cancer center advisory boards across the country. In 2010, Dr. Caligiuri was one of four individuals in the country to receive a MERIT award from the National Cancer Institute for his work on immunity and canc er, and in 2016 he received an Outstanding Investigator A ward from the National Cancer Institute. In 2018, Dr. Caligiuri was elected a Fellow of the AACR.

Dr. Caligiuri is co – founder of Pelotonia (www.pelotonia.org) , Th e Oncology Research Information Exchange Network (www.ORIENcancer.org) , CancerBridge (www.mycancerbridge.com) , and The Drug Development Institute at The Ohio State University.

Dr. Caligiuri earned his undergraduate degree from the State University of New York at Buffalo, his masters and medical degree from Stanford University School of Medicine. He completed his internship and residency in Internal Medicine at Brigham and Women’s Hospital at Harvard Medical School in Boston, MA, then completed a fellowship in medical oncology, bone marrow transplantation and immunology at the Dana – Farber Cancer Institute at Harvard Medical School. He next spent seven years at Roswell Pa rk Cancer Institute as an assistant, associate and full professor before moving to The Ohio State University in 1997, and City of Hope in 2018 .